Reza Shojaei: Every Expired Unit of Blood Tells a Story
Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources, shared on LinkedIn:
”Every expired unit of blood tells a story, and it is not a clinical one.
Blood cannot be manufactured, stockpiled indefinitely, or replaced at scale.
Yet across health systems, perfectly usable blood continues to expire while patients elsewhere face shortages.
We often explain this away as “inevitable.”
It is not.
In the latest edition of Blood and Plasma Pulse, we challenge a deeply ingrained assumption in healthcare: that blood wastage is an operational inconvenience rather than a leadership failure.
When chemotherapy or vaccines expire, executive alarms sound.
When blood expires, it is quietly normalized.
This issue explores:
- The real financial, ethical, and system-level cost of expired blood
- Why guidelines and technology alone have failed to solve the problem
- Why Patient Blood Management must move from a clinical program to an enterprise strategy
- And why leadership, not supply, is the missing variable
If blood is truly a critical healthcare infrastructure, it deserves executive ownership and accountability.
I invite healthcare leaders, policymakers, transfusion professionals, and hospital executives to read the full newsletter and reflect on a simple question: Are we managing blood or merely reacting to it?”
Read the full article here.
Stay updated with Hemostasis Today.
-
Sep 10, 2026, 05:12Douglas S. Campbell: Great to See a Strong Japanese Presence in 2026 Lasker Awards
-
Sep 10, 2026, 05:11Jan Hartmann: New Transformative Treatment for Hemophilia A
-
Sep 10, 2026, 05:09Shelby Bradford: Award-Winning Science Incoming
-
Sep 9, 2026, 17:57CRISPR/Cas Gene Editing in β-Thalassemia: From Molecular Correction to Clinical Reality
-
Sep 9, 2026, 17:38Cardiovascular Health in Bleeding Disorders – EHC
-
Sep 9, 2026, 17:33Manasvi Shah: Co-Inheritance of Alpha Globin Gene Multiplication With Beta Globin Gene Abnormalities
-
Sep 9, 2026, 17:29Christina Crossette-Thambiah: One of the Largest Studies to Date in Antiphospholipid Syndrome
-
Sep 9, 2026, 17:25Alan Nurden: A miR-146a Variant Reveals a New Pathway Linking Platelet Metabolism and Thrombosis
-
Sep 9, 2026, 17:17When Is Thrombophilia Testing Appropriate and How Can the Evidence Guide Clinical Care? – ISTH